Company Filing History:
1 out of 3,384 
1 out of 1,155 
Years Active: 2015
Title: Sunil Kumar Upadhyay: Innovator in Cancer Treatment
Introduction
Sunil Kumar Upadhyay is a notable inventor based in Ypsilanti, MI (US). He has made significant contributions to the field of medical research, particularly in the development of compounds that target specific proteins involved in cancer and other diseases.
Latest Patents
Upadhyay holds a patent for "Menin-MLL inhibitors and methods of use thereof." This invention relates to compounds that inhibit the binding of menin and MLL or MLL fusion proteins. The patent outlines compositions that include piperidine-containing compounds and methods to inhibit the interaction of menin with MLL oncoproteins. This innovation has potential applications in treating leukemia, solid cancers, diabetes, and other diseases that depend on the activity of MLL1, MLL2, and menin. He has 1 patent to his name.
Career Highlights
Throughout his career, Upadhyay has worked with prestigious institutions such as the University of Michigan and Vanderbilt University. His research has focused on developing therapeutic strategies that can significantly impact patient outcomes in oncology and related fields.
Collaborations
Upadhyay has collaborated with notable researchers, including Jolanta Grembecka and Tomasz Cierpicki. These partnerships have enhanced the depth and breadth of his research efforts.
Conclusion
Sunil Kumar Upadhyay is a prominent figure in the field of medical innovation, particularly in the development of targeted therapies for cancer. His work continues to pave the way for advancements in treatment options for various diseases.